Nasdaq · Healthcare
OmniAb, Inc. (OABIW)
As-reported financials and recent SEC filings for OmniAb, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$18.7M
Net income
$-64.8M
Net margin
—
Diluted EPS
$-0.57
ROE
-24.3%
P/E (TTM)
—
Market cap
—
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $18.7M | $26.4M | $34.2M | $59.1M | $34.7M |
| Gross profit | — | — | — | — | — |
| Operating income | $-69.0M | $-74.5M | $-69.4M | $-26.6M | $-35.6M |
| Net income | $-64.8M | $-62.0M | $-50.6M | $-22.3M | $-27.0M |
| Diluted EPS | $-0.57 | $-0.61 | $-0.51 | $-0.26 | $-0.33 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-18
View on EDGAR →42026-06-18
View on EDGAR →42026-06-18
View on EDGAR →8-K2026-06-18
View on EDGAR →42026-06-18
View on EDGAR →42026-06-18
View on EDGAR →42026-06-18
View on EDGAR →10-Q2026-05-07
View on EDGAR →Largest Healthcare peers
Go deeper on OABIW
Search OmniAb, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.